Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 110.50K | 93.40K | -- | 0.00 | 30.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 110.50K | 93.40K | -- | 0.00 | 30.00K |
| Cost of Revenue | 163.80K | 190.70K | -- | 252.60K | 240.30K |
| Gross Profit | -53.30K | -97.30K | -- | -252.60K | -210.20K |
| SG&A Expenses | 465.10K | 600.60K | 353.00K | 412.70K | 407.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 628.90K | 791.30K | 495.40K | 665.40K | 648.10K |
| Operating Income | -518.40K | -697.80K | -495.40K | -665.40K | -618.10K |
| Income Before Tax | -731.20K | -845.60K | -183.50K | -445.80K | -1.01M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -731.20K | -845.60K | -183.50K | -445.80K | -1.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -731.20K | -845.60K | -183.50K | -445.80K | -1.01M |
| EBIT | -518.40K | -697.80K | -495.40K | -665.40K | -618.10K |
| EBITDA | -492.60K | -673.50K | -484.70K | -654.60K | -607.20K |
| EPS Basic | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 78.21M | 78.21M | 72.91M | 72.24M | 72.14M |
| Average Diluted Shares Outstanding | 78.21M | 78.21M | 72.91M | 72.24M | 72.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |